Biocon slips 4% after USFDA asks for corrective measures at Malaysian unit
.webp)
Shares of Biocon slipped over 4 per cent to a low of Rs 243.50 in Wednesday's intra-day trades after the company informed that the US Food and Drug Administration (USFDA) had asked for corrective measures at its Malaysia-based subsidiary post inspection.
At 10:20 AM, Biocon was down 3.5 per cent at Rs 245.50. The counter had seen trades of around 1.1 lakh shares as against the two-week average volume of around 71,000 shares on the BSE. Meanwhile, the S&P BSE Sensex quoted flat around 66,440 level.
Biocon in an exchange filing today said, Biocon Sdn Bhd., a step-down subsidiary of Biocon Biologics, has received a communication from the USFDA pursuant to its July 2023 cGMP inspection at its insulins manufacturing facility at Johor, Malaysia. The USFDA has determined the inspection classification as 'OAI' Official Action Indicated). The OAI status may cause delay and/or withholding of pending product approvals or supplements from the facility.
The company further stated that they had submitted a comprehensive Corrective and Preventive Action (CAPA) plan to the USFDA in response to observations, and believe that they were on track to complete all actions as committed.
The said observations may not have a material impact on the manufacturing and distribution of the company’s commercial products for the US market, the release added.
Earlier this month, the USFDA had rejected the Biocon's Insulin Aspart application, a proposed biosimilar for diabetes treatment, in CRL (Complete Response Letter).
The USFDA said, it issued a CRL to convey to the company that its initial review of an application is complete, and it cannot approve the application in its present form.
That apart, in October 2023, Biocon announced a partnership with Juno Pharmaceuticals, a specialty pharmaceutical firm based in Canada, for the commercialisation of Liraglutide, a drug-device combination intended for the treatment and management of Type 2 diabetes and obesity in the Canadian market.
The company is scheduled to announce its Q2 results on November 10. The stock has been a underperformer so far in 2023, down 7 per cent, in comparision the Sensex has gained 8.4 per cent.
Other Latest News
.webp)
After Haryana, the BJP would also sweep the upcoming assembly elections in Maharashtra and Jharkhand, BJP president J P Nadda asserted on Friday.
Nadda, who paid obeisance at the Shri Naina Devi temple here, said the people were happy with the performance of the BJP government at the Centre led by Prime Minister Narendra Modi.
.webp)
Noel Tata, half-brother of the late Ratan Tata, has been unanimously elected as the chairman of Tata Trusts following the passing of the legendary industrialist Ratan Tata, CNBC-TV18 reported on Friday. Noel Tata is already a key trustee of the Sir Dorabji Tata Trust and the Sir Ratan Tata Trust. He will now lead the trusts that hold a controlling stake in Tata Sons, the primary holding company of the Tata Group.
The move has long been anticipated, given Noel Tata’s close involvement with Tata Trusts and his extensive experience within the conglomerate.
.webp)
After the Haryana poll debacle, Congress MP and LoP Rahul Gandhi attended the review meeting called by party president Mallikarjun Kharge at his residence in Delhi. Among those present were the party's Haryana observers Ashok Gehlot, Ajay Maken, Deepak Babaria and KC Venugopal.
Sources said that the Congress MP remained largely quite, but when his turn came, he observed two things; one being that Electronic Voting Machines (EVM) and the Election Commission of India (EC) "have much to answer" and another was that "the local leaders were more interested in their own progress than that of the party", leaving a loud silence in the room.
.webp)
Former US President Donald Trump, who is campaigning for another term in the White House, promised to introduce a system of "reciprocal tariffs" if re-elected. In an economic policy speech in Detroit on Thursday, the Republican candidate singled out India, claiming it imposes some of the highest tariffs on foreign goods among major global economies.
This is not the first time Trump has criticised India for its tariffs. Just last month, he called the nation a "big abuser" of US trade relations.
.webp)
Tamil Nadu Chief Minister M K Stalin has announced a bonus and ex-gratia for 2.75 lakh employees of state public sector undertakings and statutory boards for the 2023-24 fiscal.
Accordingly, all eligible workers of profit making PSUs under group C and D will be paid a minimum bonus of Rs 8,400 and a maximum of Rs 16,800, amounting to 8.33 per cent bonus and an ex-gratia of 11.67 per cent, an official release here said.
.webp)
.webp)
.webp)
.webp)
.webp)
